Major Leap in Life Sciences: Illumina Launches NovaSeq Sequencing System

In September 2016, Illumina, the global leader in gene sequencing, unveiled its next-generation sequencing platform, the NovaSeq Series. The NovaSeq platform was designed to complete whole-genome sequencing at a fraction of the cost and at much faster speeds, representing a major breakthrough in Life Sciences.

The release of this technology greatly accelerated the progress of future industries—precision medicine, cancer diagnostics, and gene therapy research. By lowering sequencing costs, NovaSeq made large-scale genomics studies and clinical applications feasible, attracting further investment from global investment firms into genetic technology companies.